Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Scalable Capital is valued in excess of $460m following a round that lifted the digital wealth manager's total funding to about $130m.

UC Berkeley's genetic drug developer 4DMT has pulled away from a proposed $100m offering after closing series C funding last month.

Mingdu Intelligent, backed by three Chinese academic institutions, has increased its funding haul to at least $26m.

Vesigen has attracted Leaps by Bayer to commercialise drug delivery technology invented by Quan Lu at Harvard School of Public Health.

Dexterity, a logistics robot spinout of Stanford, has emerged from stealth with series A funding and debt financing from Stanford-StartX Fund.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Boehringer Ingelheim Venture Fund followed an investment last September by contributing to a $26.8m round for the Basel spinout.

The total has dipped slightly from 25 year-on-year despite Purdue reporting more disclosures and patents this fiscal year.

UPMC Enterprises has contributed to a $20m series B extension for Cerevance, which is commercialising Rockefeller University research.